NeuroPathways Intervention for Brain Tumor Patients
This study is testing a program called the NeuroPathways Intervention for people recently diagnosed with a malignant (high-grade) brain tumor. The program includes an information guide and four one-on-one coaching sessions to help you cope with your diagnosis. Researchers want to see if this program is practical to carry out and if patients find it helpful. You would use the guide, attend coaching sessions, and complete short surveys at three different times. Some participants may also be asked for feedback through exit interviews. This study is currently unclear on its status, and plans to enroll 50 participants.
- Study design
- This is a pilot randomized controlled trial, meaning participants will be randomly assigned to different groups. It plans to enroll 50 participants.
- What's involved
- You would take part in coaching sessions, use an information guide, and complete short surveys at three different points in time. Some participants will also share feedback through exit interviews.
- Compensation
- Not stated in the trial record.
- Follow-up
- The main goals of the study will be measured at 2 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
NeuroPathways Intervention for Brain Tumor Patients
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Deborah A Forst, MD · PRINCIPAL_INVESTIGATOR · Massachusetts General Hospital
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Feasibility of the Intervention: Percentage of Eligible Patients Who Enroll and Participate in the Intervention2 years
The investigators will assess feasibility by examining the percentage of eligible patients who agree to enroll in the study and the percentage of enrolled patients who participate in all four intervention sessions. The intervention will be deemed feasible if at least 60% of eligible patients enroll in the study and if at least 60% of enrolled patients complete all four sessions.
- Acceptability of the Intervention: Percentage of Participants who Have High Satisfaction with the Intervention2 years
The investigators will assess acceptability via examining the distribution of patient scores for the 8-item Client Satisfaction Questionnaire (CSQ-8). CSQ-8 scores range from 8 to 32, with higher scores indicating higher satisfaction. The intervention will be deemed acceptable if at least 80% of patients score at least 20 points on the CSQ-8.